Tokyo

London

New York

finscreener facebook fan page

finscreener twitter page

finscreener linkedin page

GlobeImmune, Inc.

TRADE

NASDAQ: GBIMHealthcare / Biotechnology / USA
0.18-0.02-10.00%Vol 30 0001Y Perf -69.49%
Nov 15th, 2018 00:00
BID0.00 ASK0.00
Open0.18 Previous Close0.20
Pre-Market- After-Trading-
 - -%  - -%
Target Price
- 
Analyst Rating
— — 0.00
Potencial %
- 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12M
-/-/- 
Value Ranking
 —    -
Insiders Value % 3/6/12M
-/-/- 
Growth Ranking
 —    -
Insiders Shares Cnt. % 3/6/12M
-/-/- 
Income Ranking
 —    -
Market Cap (mil)1 
Earnings Rating
Price Range Ratio 52wk %
0.00 
Earnings Date

Today's Price Range

0.180.18

 

52wk Range

0.180.70

Summary:

Sell

Technical Indicators: Neutral
Moving Averages: Strong Sell
Performance
1 Month
-5.26%
3 Months
-50.00%
6 Months
-56.10%
1 Year
-69.49%
3 Years
-91.67%
5 Years
-

Quotes

Name / TickerPriceChg.Chg.%
GBIM0.18-0.0200-10.00
AAPL193.532.12001.11
GOOG1 061.49-3.2200-0.30
MSFT108.291.01000.94
XOM78.960.77000.98
WFC52.940.12000.23
JNJ145.991.49001.03
FB139.53-4.3200-3.00
GE8.02-0.1500-1.84
JPM109.99-0.0800-0.07
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio 2.10
Current Ratio 2.30
Long Term Debt to Total Capital -
Total Debt to Equity -
Interest Coverage -
Leverage Ratio -
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin-
EBIT Margin-33.30
EBITDA Margin-31.20
Pre-tax Profit Margin-71.70
Profit Margin-
ValuationValueIndustryS&P 500US Markets
PE Ratio -
PB Ratio 1.54
PS Ratios -
Price to Cash Flow 23.40
Price to Free Cash Flow -
Cash Flow Per Share -1.03
Price to Tangible Book0.93
Book Value per Share0.37
Enterprise Value (in ths.)-5 387
Management EffectivenessValueIndustryS&P 500US Markets
Return on Equity (5Y Avg)8.88
ROE last 12 Months -66.24
Return on Assets (5Y Avg) -91.56
ROA last 12 Months -16.41
Return on Capital (5Y Avg) -
ROC last 12 Months -66.24
Return on invested Capital Q -33.56
Return on invested Capital Y-64.41
Assets Turnover-
Receivables Turnover-
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)-
Revenue per Share -
Revenue Growth 3 Years -
Revenue Growth 5 Years -
DividendsValueIndustryS&P 500US Markets
Dividend Yield -
Dividend Rate -
Dividend Growth 3 Years-
Dividend Growth 5 Years-

Earnings HistoryEstimateReportedSurprise %
Q01 2016--0.15-
Q04 2015--0.14-
Q03 2015--0.13-
Q02 2015--0.23-
Q01 2015--0.27-
Q03 2014--0.64-
Q02 2014--1.25-
----
Earnings Per EndEstimateRevision %Trend
----
----
----
----
Next Report Date6th Jul 2017
Estimated EPS Next Report-
Estimates Count-
EPS Growth Next 5 Years %-
Volume Overview
Volume30 000
Shares Outstanding (in ths.)5 750
Trades Count1
Dollar Volume900
Avg. Volume24 586
Avg. Weekly Volume214 740
Avg. Monthly Volume90 055
Avg. Quarterly Volume58 565

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

56%44%

Bearish Bullish

64%36%

Bearish Bullish

60%40%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
0
0
0
Moderate Buy
0
0
0
Hold
0
0
0
Moderate Sell
0
0
0
Strong Sell
0
0
0
Rating---

There are no comments yet.

News

x